Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Gilead's COVID-19 hopeful remdesivir may get swift Japanese approval: report
Fierce Biotech
Mon, 04/27/20 - 09:40 am
Japan
Gilead Sciences
remdesivir
COVID-19
Here's What to Expect With Gilead Sciences' Q1 Earnings Update
Motley Fool
Mon, 04/27/20 - 09:23 am
Gilead Sciences
earnings
AbbVie, Lilly and Gilead stay on top of pharma ad spending list for March amid steady overall spending
Fierce Pharma
Mon, 04/27/20 - 09:21 am
AbbVie
Eli Lilly
Gilead Sciences
pharma advertising
DTC ads
television ads
pandemic
COVID-19
Gilead charges CDC with contract breach on HIV research
Seeking Alpha
Sun, 04/26/20 - 08:31 pm
Gilead Sciences
CDC
patents
lawsuits
HIV
R&D
While Big Pharma Tanked, Gilead Sciences and Regeneron Soared
Motley Fool
Sat, 04/25/20 - 11:34 pm
Big Pharma
Gilead Sciences
Regeneron
One leak good, two leaks bad for Gilead
EP Vantage
Fri, 04/24/20 - 10:50 am
Gilead Sciences
remdesivir
data leaks
China
COVID-19
coronaviruses
Did Gilead's remdesivir flop a Chinese trial? Analysts beg to differ
Fierce Biotech
Thu, 04/23/20 - 09:12 pm
Gilead Sciences
remdesivir
COVID-19
China
pandemic
clinical trials
Gilead, Kite pen natural killer pact with little-known Australian cell therapy player
Fierce Biotech
Wed, 04/22/20 - 11:04 am
Gilead Sciences
Kite Pharma
oNKo-innate
CAR-T
natural killer cell therapies
Report: Congressman wants SEC investigation into Gilead Covid-19 data leak
MedCity News
Tue, 04/21/20 - 12:13 pm
legal
SEC
Gilead Sciences
remdesivir
NASDAQ
COVID-19
There's More to Gilead Sciences' Remdesivir Data Than Meets the Eye
Motley Fool
Tue, 04/21/20 - 12:10 am
Gilead Sciences
remdesivir
COVID-19
pandemic
COVID-19: New animal data back up Gilead's remdesivir as other treatment candidates emerge
Fierce Biotech
Mon, 04/20/20 - 10:38 am
Gilead Sciences
COVID-19
remdesivir
R&D
Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment
Stat
Thu, 04/16/20 - 11:44 pm
Gilead Sciences
remdesivir
clinical trials
COVID-19
Gilead Is Said to Hold Arcus Stake Talks, Spurring 54% Rally
Bloomberg
Wed, 04/15/20 - 11:22 pm
Gilead Sciences
Arcus Biosciences
Alphabet
First study of Gilead’s remdesivir in COVID-19 reveals little
Pharmaforum
Mon, 04/13/20 - 09:55 pm
Gilead Sciences
COVID-19
remdesivir
Early Look at Gilead Sciences' Experimental Coronavirus Treatment Disappoints
Motley Fool
Sat, 04/11/20 - 11:09 pm
Gilead Sciences
COVID-19
remdesivir
pandemic
5 Biotech Stocks Winning the Coronavirus Race
Motley Fool
Sat, 04/11/20 - 10:52 pm
COVID-19
pandemic
drug development
Regeneron
Kevzara
Gilead Sciences
remdesivir
Inovio
INO-4800
vaccines
Moderna Therapeutics
mRNA-1273
Novavax
NVX-CoV2373
All Eyes on Gilead’s Readout of Remdesivir for COVID-19
BioSpace
Fri, 04/10/20 - 10:36 am
Gilead Sciences
clinical trials
remdesivir
COVID-19
Calling Gilead's CAR-T infringement 'willful,' judge enhances BMS' award to $1.2B
Fierce Pharma
Fri, 04/10/20 - 10:23 am
Gilead Sciences
CAR-T
patents
Bristol-Myers Squibb
Gilead supersizes remdesivir trials, changes primary endpoint
Fierce Biotech
Thu, 04/9/20 - 10:27 am
Gilead Sciences
clinical trials
COVID-19
remdesivir
Biopharma acquisitions slow, but it's not Covid-19's fault yet
EP Vantage
Wed, 04/8/20 - 10:28 am
M&A
COVID-19
Gilead Sciences
Forty Seven
Eli Lilly
Dermira
Takeda
Hypera Pharma
ANI Pharmaceuticals
Amerigen Pharma
Pages
« first
‹ previous
…
17
18
19
20
21
22
23
24
25
…
next ›
last »